Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


Apple Unveils Enhanced Apple Intelligence and Next-Generation Siri at WWDC 2026
SpaceX IPO Demand Surges Past $250 Billion Ahead of Historic Market Debut
SK Hynix Stock Rebounds as AI Memory Chip Demand Fuels Expansion Plans
oOh!media Takeover Battle Intensifies as Bain Capital Joins Competing Bids
Wizz Air Beats Profit Forecast as Cost Controls Offset Industry Challenges
GM and Peak Energy Partner to Advance Sodium-Ion Battery Technology for Grid Storage
MOL Gets More Time to Negotiate Acquisition of Russian-Owned Stake in Serbia’s NIS
BHP Port Hedland Workers Back Strike Action Amid Pay Dispute
Sigma Healthcare Shares Slide Amid Preliminary Boots Acquisition Talks
Oracle Stock Falls Despite Earnings Beat as Company Plans $40 Billion Financing for FY2027
Italy’s ITA Airways Weighs Legal Action Against Pratt & Whitney Over Grounded Airbus Fleet
J.P. Morgan Sees Major Upside for Prysmian as Optical Fiber Prices Surge
Bouygues, Orange and Iliad Strike €20.35 Billion Deal to Acquire SFR
Nvidia Expands South Korea AI Partnerships to Strengthen Data Center and Memory Chip Supply
OpenAI Eyes Massive 10GW Ohio Data Center Campus in Potential $500 Billion AI Infrastructure Deal
Trump Administration Defends Anthropic AI Restrictions in Ongoing Federal Lawsuit
Asics Considers Onitsuka Tiger Spinoff as Luxury Sneaker Brand Expands Globally 



